SurModics, Inc. (SRDX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Selling, general and administrative: 5.02M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Selling, general and administrative: 5.02M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
SurModics, Inc. (NASDAQ: SRDX) reported Q2 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $146 million versus the consensus estimate of $14.84 million.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
